OpportunityTitle: Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events - A Multicenter Program Expansion (U54)
AdditionalInformationOnEligibility: Additional Information on Eligibility The following organizations are eligible to apply: &amp;bull;          Harvard Pilgrim Healthcare, Inc.  &amp;bull;          Duke University   &amp;bull;          Washington University   &amp;bull;          University of Pennsylvania  &amp;bull;          Hektoen Institute for Medical Research
Description: The CDC Prevention Epicenters Program has been established to develop, implement and evaluate the effectiveness of epidemiologically-based strategies to improve healthcare quality and patient safety. This funding opportunity announcement is designed to utilize the CDC Prevention Epicenters Program to translate basic, epidemiologic and technologic discoveries into new strategies for improving prevention of Healthcare-Associated Infections (HAIs), Antimicrobial Resistance (AR) and other adverse events in all types of healthcare facilities in the United States. The prevention strategies could include, but are not limited to, prevention strategies currently undergoing single-center studies by the Prevention Epicenters Program that merit further investigation in multicenter studies.
GrantorContactEmailDescription: Grants Policy
GrantorContactText: Sharnell Wilson&lt;br/&gt;zcq8@cdc.gov&lt;br/&gt;
CloseDateExplanation: Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.